Shingles (Herpes Zoster): Symptoms, Antiviral Treatment, Recovery and Shingrix Vaccine

Evidence reviewed: 8 November 2026. Shingles (herpes zoster) is caused by reactivation of varicella-zoster virus (VZV), the same virus that causes chickenpox. It often begins with pain, burning, tingling or unusual skin sensitivity, followed by a blistering rash in a band on one side of the body or face. Most cases resolve over several weeks, but shingles can cause persistent nerve pain called postherpetic neuralgia (PHN) and, rarely, serious eye, ear or neurological complications. Antiviral treatment with acyclovir, valacyclovir or famciclovir works best when started within 72 hours of symptom onset. Vaccination with two doses of Shingrix is highly effective in preventing shingles and its complications in eligible adults [1–4].

Why does shingles occur after chickenpox?

After a person has chickenpox, VZV remains dormant in sensory nerve ganglia. Years or decades later it may reactivate, travel along a sensory nerve and produce pain and a vesicular rash in a defined skin region, called a dermatome. Shingles can also occur in people previously exposed to the varicella vaccine virus, although that risk is generally lower than after natural infection [1].

Shingles is not caused by catching a new virus from someone with a shingles rash. It is a reactivation of an existing latent infection. However, contact with fluid from a person’s active shingles blisters can transmit VZV to someone without immunity, potentially causing chickenpox, not immediate shingles [1,3].

Who is at higher risk of shingles?

  • Older adults: shingles risk increases with age, especially beyond 50.
  • People with weakened immunity: for example from certain cancers, organ transplants, HIV-related immunosuppression or immunosuppressive medication.
  • People with a history of prior varicella infection who remain susceptible to later reactivation.
  • Some patients with chronic illnesses or other immune-related risk factors.

Shingles can occur in healthy younger adults and even children, so age alone cannot rule out the diagnosis. Some patients develop shingles more than once. Having had shingles does not mean vaccination is unnecessary when a person meets vaccine eligibility criteria [2,3].

Early symptoms before the rash

Shingles may begin with localized pain, itching, tingling or hypersensitivity several days before blisters appear. Some patients experience malaise, headache or light sensitivity. Pain may feel burning, stabbing, electric or like a deep ache. When the rash is on the chest or abdomen, early shingles pain can be mistaken for cardiac, gallbladder, musculoskeletal or other disease [1].

Do not assume all one-sided chest or abdominal pain is shingles. New chest pain, breathlessness, fainting or other serious symptoms warrant prompt medical assessment, even if a rash later appears.

What does the shingles rash look like?

The typical eruption develops as clusters of small, fluid-filled blisters on an inflamed base in one or two neighboring dermatomes. The rash usually affects one side of the chest, back or face and often does not cross the midline. New vesicles may continue appearing for three to five days, then crust and heal over approximately two to four weeks [1].

Stage Possible findings Clinical importance
Prodrome Localized pain, tingling, burning, itch or skin sensitivity before rash. Diagnosis may be uncertain without skin lesions.
Early eruption Red, dusky or discolored patches with grouped vesicles. Prompt assessment for antiviral treatment is most useful.
Active blisters New lesions appear, often with pain and sensitivity. Fluid can transmit VZV to susceptible contacts.
Crusting and healing Blisters dry, scab and gradually resolve. Skin usually heals in 2–4 weeks; nerve pain may persist.

On darker skin, inflammation may appear purple, brown, gray or subtle rather than bright red. Atypical cases occur, especially in people with immunosuppression. Shingles without a visible rash (zoster sine herpete) is possible but difficult to confirm, and other causes of pain should be considered [1].

Shingles affecting the eye: seek urgent help

Herpes zoster ophthalmicus (HZO) involves VZV reactivation in the ophthalmic branch of the trigeminal nerve. A rash on the forehead, eyelid or tip/side of the nose, especially with eye pain, redness, light sensitivity, blurred vision or swelling, requires urgent same-day ophthalmic or emergency evaluation [1].

HZO can cause keratitis, uveitis, elevated intraocular pressure and other sight-threatening complications. Do not apply ordinary skin creams, steroid drops or household remedies to the eye. Clinicians may begin prompt systemic antiviral therapy and determine whether specialist eye treatment is needed. Eye involvement can occur even when the visible rash is limited.

Shingles involving the ear or facial nerve

Herpes zoster oticus can cause blisters near the ear, ear pain or hearing symptoms. Ramsay Hunt syndrome may include facial weakness or paralysis, hearing loss, vertigo or tinnitus along with VZV-related inflammation. These symptoms require urgent clinical assessment, both to start appropriate treatment and to distinguish other neurological emergencies such as stroke [1].

Sudden facial drooping, particularly with arm weakness, speech problems or other neurological changes, should trigger emergency stroke evaluation rather than being assumed to be shingles.

What is disseminated shingles?

Most shingles is limited to a small number of adjacent dermatomes. Disseminated zoster can produce widespread lesions away from the initial area and may involve internal organs, particularly in people with immunosuppression. Serious complications include pneumonitis, hepatitis, encephalitis and severe bacterial skin infection [1].

Widespread blistering, fever, confusion, breathing problems, severe headache, stiff neck or marked immunosuppression requires immediate evaluation. Some patients need hospitalization and intravenous acyclovir rather than outpatient tablets.

How is shingles diagnosed?

A typical painful, unilateral dermatomal eruption can often be diagnosed clinically. When the rash is atypical, widespread, difficult to distinguish from herpes simplex, or occurs in a vulnerable patient, VZV polymerase chain reaction (PCR) from a suitable lesion sample is the preferred laboratory method [1].

Blood antibody testing generally is not the best way to confirm an ordinary acute shingles rash, because many adults have antibodies from past chickenpox or vaccination. Testing and infection-control precautions are individualized. Atypical vesicles can also be due to herpes simplex, contact dermatitis, impetigo, insect bites or other skin disease.

Antiviral medicines: treat early

The CDC identifies three preferred antivirals for herpes zoster: acyclovir, valacyclovir and famciclovir. They inhibit viral DNA replication, reducing new lesion formation, shedding and acute disease severity [1]. Treatment is most effective when started within 72 hours of symptom onset, so patients should seek care promptly.

Medicine Typical role Important precautions
Valacyclovir Oral prodrug of acyclovir, commonly used for uncomplicated shingles. Kidney-function dose adjustment may be needed; adequate hydration and drug-interaction review.
Famciclovir Oral prodrug of penciclovir; an alternative for eligible patients. Renal adjustment and possible headache, GI effects or other adverse reactions.
Acyclovir Oral treatment in uncomplicated cases; intravenous therapy for selected severe cases. Renal toxicity and neurotoxicity risk in susceptible patients, especially with inappropriate doses.

Antiviral selection and dose depend on age, kidney function, pregnancy, immune status and severity. Oral regimens are often prescribed for around seven days in uncomplicated adult disease, but the exact preparation and schedule differ. Do not copy an adult antiviral dose into a child or a patient with significant kidney impairment.

What if the rash started more than 72 hours ago?

Do not assume treatment is pointless after 72 hours. A clinician may still consider antivirals in patients with new lesions, significant ongoing disease, eye or ear involvement, immunosuppression or other complications. The 72-hour window describes when efficacy is greatest, not an absolute reason to ignore a person with severe or high-risk disease [1].

Prompt evaluation is still essential because the risk of vision or neurological complications may require treatment or specialist input regardless of how long the rash has been present.

Pain management during acute shingles

Acute shingles pain ranges from mild discomfort to severe neuropathic pain. Treatments may include acetaminophen/paracetamol or a suitable NSAID if appropriate, plus individualized prescription strategies when pain is substantial. Clinicians must consider kidney disease, stomach bleeding, anticoagulants, other medicines and age before selecting analgesics.

For severe neuropathic pain, medications such as gabapentin or pregabalin may be considered in selected patients, with careful assessment of sedation, falls, respiratory interactions and renal dosing. Avoid unmonitored combinations with alcohol, opioids or other sedatives.

What is postherpetic neuralgia (PHN)?

Postherpetic neuralgia is persistent nerve pain in the affected area after shingles, commonly defined in research as pain continuing more than 90 days after rash onset. It is the most common shingles complication, affecting roughly 10–18% of people with shingles, with risk increasing significantly with age [1].

PHN pain may be burning, electric, stabbing or aching, sometimes with allodynia—pain from light touch or clothing. It can disturb sleep and severely affect function for months or years. Risk is higher in older adults, people with severe acute pain and those with a large rash [1].

How is postherpetic neuralgia treated?

Depending on severity, comorbidities and local guidance, clinicians may consider gabapentin or pregabalin, selected tricyclic antidepressants such as nortriptyline, or topical lidocaine on healed intact skin. Treatment usually requires gradual adjustment and side-effect monitoring. The correct choice is influenced by falls risk, kidney function, cognitive status, other medicines and pain pattern.

Topical lidocaine should not be applied casually to open blisters or damaged skin. Strong opioids are generally not preferred for routine long-term neuropathic pain because of dependence, sedation and other harms. If pain remains severe, specialist pain or neurology referral may be valuable.

Do corticosteroids treat shingles?

Systemic corticosteroids are not recommended as stand-alone treatment for herpes zoster. Selected patients may receive steroids for a particular complication or under specialist protocols, but steroids do not replace antivirals and may be harmful in immunocompromised patients or those with uncontrolled diabetes or infection. They have not been shown reliably to prevent PHN.

Similarly, antibiotics do not treat VZV. They are appropriate only when a separate bacterial skin infection is diagnosed or strongly suspected. Herbal creams, high-dose vitamin regimens and “immune detox” products have not been demonstrated to cure shingles.

Home care and recovery

  • Keep the rash clean and dry and cover it with loose, nonstick dressing if practical.
  • Use cool wet compresses for comfort, not extreme ice exposure or aggressive rubbing.
  • Avoid scratching or picking blisters, which increases secondary infection risk.
  • Wear loose clothing and rest as needed while maintaining adequate hydration and nutrition.
  • Use prescribed antivirals and pain relief as directed.
  • Report new spreading redness, pus, fever, worsening pain or unusual neurological symptoms.

Most skin lesions crust and heal within two to four weeks. Color changes can take longer to fade, and PHN may persist after the skin appears healed. Persistent pain is real and should be assessed rather than dismissed because blisters have gone away.

Is shingles contagious?

Someone with shingles can transmit VZV through contact with blister fluid to a susceptible person, causing chickenpox. The risk is lower when the rash is covered, and the person is generally no longer infectious once all lesions have crusted [3].

Until crusting is complete:

  • Cover the rash if possible and wash hands frequently.
  • Avoid touching or scratching lesions and do not share dressings or towels that contact active lesions.
  • Avoid close contact with pregnant people without varicella immunity, premature or low-birth-weight infants and people with weakened immunity.
  • Healthcare workers and immunocompromised patients may require additional work or isolation precautions according to facility policy and whether zoster is localized or disseminated.

Shingles is not generally transmitted through everyday casual interaction when lesions are fully crusted. Immunocompromised people with disseminated lesions may have greater transmission risk and need specialist infection-control measures.

Shingrix: who should receive the shingles vaccine?

In the United States, the CDC recommends two doses of recombinant zoster vaccine (RZV, Shingrix) for:

  • All adults aged 50 years and older, regardless of whether they previously had shingles.
  • Adults aged 19 years and older who are or will be immunodeficient or immunosuppressed because of disease or treatment [2,4].

For immunocompetent adults, the doses are usually given two to six months apart. For some immunocompromised patients who benefit from completing vaccination sooner, the second dose may be given one to two months after the first under clinical guidance [2]. If more than six months pass after dose one, give dose two as soon as feasible; do not restart the series.

Shingrix is a recombinant, non-live vaccine, not the older live zoster vaccine. Its use in patients with immunosuppression requires proper timing relative to immune-modifying therapy to optimize response [2,4].

How effective is Shingrix?

The CDC reports over 90% effectiveness in preventing shingles and PHN among immunocompetent adults aged 50 years and older, based on the studied populations and schedules [3]. Protection in immunocompromised groups varies by the underlying condition and immune status.

Common adverse effects include injection-site pain, fatigue, muscle pain, fever or chills for a short period. These generally resolve. Serious allergic reactions are rare but need urgent care. A prior history of shingles or the older live zoster vaccine usually does not remove the recommendation to receive Shingrix [2].

Can someone be vaccinated during an active shingles episode?

Shingrix is preventive, not treatment for an active infection. CDC recommends not administering it during an active shingles episode. Vaccination can be considered after the acute illness resolves, using local advice and individual immunization history. In the United States, there is no required specific long waiting interval after previous shingles once the acute episode has resolved [2].

Pregnancy: CDC currently has no routine recommendation for recombinant zoster vaccination during pregnancy; vaccination is generally deferred until after pregnancy. People with suspected lack of varicella immunity need assessment of varicella vaccination rather than assuming Shingrix is a substitute for the chickenpox vaccine [2].

Shingles in pregnancy and immunocompromised patients

Shingles during pregnancy is different from a primary chickenpox infection in a susceptible pregnant person, which can carry specific fetal and maternal risks. Any new blistering rash in pregnancy warrants a diagnosis and medicine review. Immunocompromised patients may have more widespread or prolonged disease and may need urgent treatment even when the rash seems atypical [1].

Antiviral choice and dose should consider pregnancy, kidney function, immune status and other medications. Do not delay expert assessment of facial lesions, neurological symptoms or disseminated infection.

Frequently asked questions

Can shingles occur twice?

Yes. Recurrence is possible, and eligible adults should still discuss Shingrix vaccination [2].

Does the shingles rash cross the middle of the body?

Typical localized shingles usually stays within one or adjacent dermatomes on one side, but atypical or disseminated disease can differ [1].

Is it too late for antivirals after 72 hours?

Not always. New lesions, eye disease, immunosuppression or severe complications can justify treatment assessment beyond this window.

Can touching shingles cause shingles in another person?

It can transmit VZV to a susceptible person, potentially causing chickenpox rather than immediate shingles [3].

Can shingles damage vision?

Yes. A forehead/eyelid/nose rash or eye symptoms needs urgent clinical and often ophthalmology assessment [1].

Is Shingrix recommended after a previous episode?

Yes, for eligible patients, after the acute illness has resolved [2].

Is the vaccine one dose?

No. Shingrix requires a two-dose series under current CDC guidance [2].

Key takeaways

Shingles is VZV reactivation that often causes a painful one-sided blistering rash. Seek assessment promptly for antiviral therapy, ideally within 72 hours, and urgently for eye, ear, neurological or disseminated symptoms. PHN may persist after the rash heals. Two Shingrix doses provide strong prevention for eligible adults.

References

  1. Centers for Disease Control and Prevention. Clinical overview of shingles (herpes zoster). CDC; accessed 8 Nov 2026.
  2. Centers for Disease Control and Prevention. Shingles vaccine recommendations for healthcare professionals. CDC; updated 2024.
  3. Centers for Disease Control and Prevention. About shingles: symptoms, spread, prevention and treatment. CDC; accessed 8 Nov 2026.
  4. Centers for Disease Control and Prevention. Shingles vaccination: who needs Shingrix. Updated 19 Aug 2025.
  5. Centers for Disease Control and Prevention. Clinical features of shingles, postherpetic neuralgia and disseminated disease. CDC; updated 2024.

Medical disclaimer: Educational material only. Suspected shingles—especially on the face or near the eye—requires prompt medical assessment, and antiviral prescribing must account for individual kidney function and health. Visual changes, facial weakness, confusion, widespread blisters or other severe symptoms warrant urgent emergency or specialist care.

Medical & AI Disclaimer

The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.

We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.

Leave a Reply

Your email address will not be published. Required fields are marked *